A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
- Status
- UNKNOWN
- Phase
- N/A
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).
- Status
- RECRUITING
- Phase
- N/A
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
- Status
- RECRUITING
- Phase
- N/A
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
NYSCF Scientific Discovery Biobank
- Status
- RECRUITING
- Phase
- N/A
Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Choices About Genetic Testing And Learning Your Risk With Smart Technology
- Status
- COMPLETED
- Phase
- NA
Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
- Status
- RECRUITING
- Phase
- PHASE2
PRO1107 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HRD Tests for Ovarian cancER
- Status
- RECRUITING
- Phase
- PHASE2
The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life
- Status
- COMPLETED
- Phase
- NA
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- NA